A Study to Find the MTD of SYN125 in People With Solid Tumors and the MTD of SYN125 With a Fixed Dose of SYN004 in People in Patients With Epithelial Cancers With EGFR Expressions

NCT04363242 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Epithelial Carcinoma
Solid Tumor

Interventions

BIOLOGICAL: SYN125
BIOLOGICAL: SYN004

Sponsor

Synermore Biologics Co., Ltd.

Collaborators

[object Object]